Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.

@article{Xiong2015NonvitaminKA,
  title={Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.},
  author={Qinmei Xiong and Yee Cheng Lau and Keitaro Senoo and Deirdre A Lane and Kui Hong and Gregory Y. H. Lip},
  journal={European journal of heart failure},
  year={2015},
  volume={17 11},
  pages={1192-200}
}
BACKGROUND No pooled analysis has been undertaken to assess the efficacy and safety of the non-vitamin K antagonist oral anticoagulants (NOACs) compared with warfarin in the subgroup of patients with atrial fibrillation (AF) and heart failure (HF), including edoxaban data from recent randomized controlled trials (RCTs). METHODS Comprehensive literature searches were conducted using the Cochrane Library, MEDLINE, and Scopus databases from inception to April 2015. Statistical analyses were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Quality of anticoagulation control in preventing adverse events in heart failure patients in sinus rhythm: a Warfarin Aspirin Reduced Cardiac Ejection Fraction Trial (WARCEF) Substudy

  • S Homma, JL Thompson, +18 authors WARCEF Investigators
  • Circ Heart Fail
  • 2015
Highly Influential
1 Excerpt

Similar Papers

Loading similar papers…